Literature DB >> 18424062

Quality of life and anxiety and depressive disorder comorbidity.

Melissa M Norberg1, Gretchen J Diefenbach, David F Tolin.   

Abstract

The present investigation evaluated the relations among anxiety and depressive disorder comorbidity and quality of life (QOL) by utilizing self-report measures of life satisfaction and functional disability. Participants were 94 individuals who were presented for treatment at an outpatient anxiety disorders clinic and 26 nonclinical participants. Results indicated that participants diagnosed with anxiety disorders reported lower QOL than did nonclinical participants. Anxiety disorder comorbidity did not additionally impact QOL; however, presence of a depressive disorder comorbid with an anxiety disorder did negatively impact QOL as these individuals reported significantly more functional disability and less life satisfaction than did individuals with anxiety disorders alone or those without a psychiatric diagnosis. These results highlight the negative nature of anxiety disorders and improve clarification on the role of diagnostic comorbidity on QOL among those with an anxiety disorder.

Entities:  

Mesh:

Year:  2008        PMID: 18424062     DOI: 10.1016/j.janxdis.2008.03.005

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  20 in total

1.  Social Support Buffers the Impact of Depressive Symptoms on Life Satisfaction in Old Age.

Authors:  Tangeria R Adams; Laura A Rabin; Valdiva G Da Silva; Mindy J Katz; Joshua Fogel; Richard B Lipton
Journal:  Clin Gerontol       Date:  2015-08-07       Impact factor: 2.619

2.  Examining the Psychometric Properties of the Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire in Two Samples of Youth with OCD.

Authors:  B Wellen; L C Skriner; J Freeman; E Stewart; A Garcia; J Sapyta; M Franklin
Journal:  Child Psychiatry Hum Dev       Date:  2017-02

3.  The Effect of Sertraline on the Quality of Life for Children and Adolescents with Anxiety Disorder.

Authors:  Nursu Çakin Memik; Işık Karakaya; Özlem Yildiz; Şahika Şişmanlar; Çiğdem Çağlayan; Belma Ağaoğlu
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

4.  Functioning and disability levels in primary care out-patients with one or more anxiety disorders.

Authors:  C D Sherbourne; G Sullivan; M G Craske; P Roy-Byrne; D Golinelli; R D Rose; D A Chavira; A Bystritsky; M B Stein
Journal:  Psychol Med       Date:  2010-02-11       Impact factor: 7.723

5.  Anxiety symptoms have a direct effect on oral health perception in young women.

Authors:  Francine S Costa; Mariana G Cademartori; Manuela F Silva; Gustavo G Nascimento; Ayah Q Shqair; Ricardo T Pinheiro; Flávio F Demarco; Marília L Goettems
Journal:  Qual Life Res       Date:  2018-02-01       Impact factor: 4.147

6.  Social criticism moderates the relationship between anxiety and depression 10 years later.

Authors:  Kayla A Lord; Nicholas C Jacobson; Michael K Suvak; Michelle G Newman
Journal:  J Affect Disord       Date:  2020-05-21       Impact factor: 4.839

Review 7.  Epigenetic mechanisms underlying extinction of memory and drug-seeking behavior.

Authors:  Melissa Malvaez; Ruth M Barrett; Marcelo A Wood; Carles Sanchis-Segura
Journal:  Mamm Genome       Date:  2009-09-30       Impact factor: 2.957

8.  Quality of life impairment in generalized anxiety disorder, social phobia, and panic disorder.

Authors:  Terri L Barrera; Peter J Norton
Journal:  J Anxiety Disord       Date:  2009-07-14

9.  Gender and age differences in domain-specific life satisfaction and the impact of depressive and anxiety symptoms: a general population survey from Germany.

Authors:  Isolde Daig; Peter Herschbach; Anja Lehmann; Nina Knoll; Oliver Decker
Journal:  Qual Life Res       Date:  2009-05-09       Impact factor: 4.147

10.  Consequences of visual height intolerance for quality of life: a qualitative study.

Authors:  Florian Schäffler; Martin Müller; Doreen Huppert; Thomas Brandt; Theresa Tiffe; Eva Grill
Journal:  Qual Life Res       Date:  2013-08-22       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.